InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ray Russell T. Officer active across 2 companies, notably Merrimack Pharmaceuticals INC. In total, 7 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €3k. History available since 31 December 2021. The latest transaction was filed on 4 September 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Ray Russell T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
21,455 shares@ US$1.3634.1% of flowCommon StockSEC:0001213900-23-075377:0
30,702 shares0Common StockSEC:0001213900-22-068720:0
13,068 shares0Common StockSEC:0001213900-22-042959:0
10,570 shares@ US$1.3617.1% of flowCommon StockSEC:0001213900-22-042957:0
10,570 shares@ US$1.3625.6% of flowCommon StockSEC:0001213900-22-028982:0
4,728 shares@ US$3.0423.6% of flowCommon StockSEC:0001213900-22-002425:0
1,000 shares@ US$3.8398100.0% of flowCommon StockSEC:0000899243-22-000473:0
7 of 7 declarations
About Ray Russell T
Ray Russell T is a declarant linked to 180 Life Sciences Corp. and Merrimack Pharmaceuticals INC, where he is a director. The record shows 7 filings in total. In the sampled recent filings, the period runs from 2022-01-04 to 2023-09-08, with EUR 0 of buys and EUR 3391 of sells, and the stated transaction nature is Attribution.
